Mannkind's inhaled insulin clears big hurdle

Danbury-based MannKind's hopes for Afrezza, an inhaled diabetes drug, took a major step forward this week when an advisory panel recommended the Food and Drug Administration approve the treatment.



via Danbury Newswire http://ift.tt/1pT4iU2